Triple-negative breast cancer: IHC biomarker classification clearly delineates triple-negative breast cancer, identified by the absence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) proteins [146]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.